|
| 37229045 | A comparison of the outcomes of a novel technique of Mini-Incision and Self-Express (MISE) for breast abscess with the conventional techniques: a retrospective comparative cohort study. | | 2023 |
| 38073235 | Immunohistochemistry Detection of Histone H3 K27M Mutation in Human Glioma Tissue. | | 2023 |
| 37476329 | Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Neurooncol Adv | 2023 |
| 37010875 | Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. | Neuro Oncol | 2023 |
| 35137635 | Ultrasonic Percutaneous Tenotomy for Recalcitrant Lateral Elbow Tendinopathy: Clinical and Sonographic Results at 90 Months: Response. | American Journal of Sports Medicine | 2022 |
| 35997552 | Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas. | J Neuropathol Exp Neurol | 2022 |
| 35402891 | Performance of Serum β2-Microglobulin- and β-Trace Protein-Based Panel Markers and 2021 Creatinine- and Cystatin-Based GFR Estimating Equations in Pakistan. | Kidney Med | 2022 |
| 36382108 | Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. | Neurooncol Adv | 2022 |
| 35219582 | Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials. | Cytotherapy | 2022 |
| 34724065 | EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. | Neuro Oncol | 2022 |
| 33336845 | Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children. | Pediatr Blood Cancer | 2021 |
| 34125480 | Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. | Pediatr Blood Cancer | 2021 |
| 34064668 | Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital. | J Pers Med | 2021 |
| 34224367 | Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. | Mol Cancer Ther | 2021 |
| 33507822 | NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. | J Clin Oncol | 2021 |
| 33140540 | A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. | Pediatr Blood Cancer | 2021 |
| 33073916 | Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma. | Pediatric Blood and Cancer | 2021 |
| 32839179 | Diffuse midline glioma with novel, potentially targetable, fusion. | Cold Spring Harbor molecular case studies | 2020 |
| 32304218 | Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial. | Neuro Oncol | 2020 |
| 32236425 | A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study. | Neuro Oncol | 2020 |
| 32594172 | Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma. | J Neuropathol Exp Neurol | 2020 |
| 30559168 | Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. | Clin Cancer Res | 2019 |
| 31626572 | Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. | J Clin Oncol | 2019 |
| 31553442 | Primary CNS Alveolar Rhabdomyosarcoma: Importance of Epigenetic and Transcriptomic Assays for Accurate Diagnosis. | J Neuropathol Exp Neurol | 2019 |
| 29948766 | Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2. | J Neurooncol | 2018 |
| 30505221 | Comparison of hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1. | | 2018 |
| 30392092 | Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials. | J Neurooncol | 2018 |
| 28968170 | Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. | J Clin Oncol | 2017 |
| 23652864 | Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor. | Journal of Pediatric Hematology/Oncology | 2016 |
| 27332770 | Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials. | Pediatr Blood Cancer | 2016 |
| 26960263 | Utility of positron emission tomography in schwannomatosis. | Journal of Clinical Neuroscience | 2016 |
| 27406584 | Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors. | Journal of Neuro-Oncology | 2016 |
| 27312077 | Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series. | Child's Nervous System | 2016 |
| 26684767 | The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience. | J Neurosurg Pediatr | 2016 |
| 26101244 | Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. | J Clin Oncol | 2015 |
| 25346052 | Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. | Pediatric Blood and Cancer | 2015 |
| 25965575 | Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. | Cancer Cell | 2015 |
| 25381154 | The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients. | Cancer Res | 2015 |
| 26054044 | Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study. | Pediatr Blood Cancer | 2015 |
| 26118663 | Management of CNS germinoma. | CNS Oncol | 2015 |
| 24700239 | Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study. | Journal of Neuro-Oncology | 2014 |
| 24123865 | A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. | Pediatr Blood Cancer | 2014 |
| 24311643 | Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. | Neuro Oncol | 2014 |
| 24038913 | Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group. | Pediatr Blood Cancer | 2014 |
| 24249158 | Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. | Pediatr Blood Cancer | 2014 |
| 23934933 | Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. | Pediatr Blood Cancer | 2014 |
| 24803676 | Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. | Neuro Oncol | 2014 |
| 24847085 | Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. | Neuro Oncol | 2014 |
| 23508296 | Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. | J Neurooncol | 2013 |
| 24249802 | Functional outcome measures for NF1-associated optic pathway glioma clinical trials. | Neurology | 2013 |